Recombinant Methanococcus maripaludis UPF0237 protein MMP0657, abbreviated as MMP0657, is a protein derived from the archaeon Methanococcus maripaludis . This protein belongs to the UPF0237 family and is annotated as a conserved hypothetical protein .
Characteristics and Properties:
Protein Length: Full length protein, consisting of 90 amino acids
Molecular Weight: The molecular weight can be estimated based on the amino acid sequence, but is not specified .
Sequence: The amino acid sequence of MMP0657 is: MENVVITVVG VDKPGIVAEV TKVLAQNSAN IVDIRQTIME DLFTMIMLVD ISKISSDFSE LNVALEKLGS EIGVKINVQH ENIFKYMHRI
Methanococcus maripaludis is a hydrogenotrophic methanogen that converts carbon dioxide and hydrogen into methane, a cleaner energy fuel . It is a genetically tractable model organism used in various biotechnology studies . The M. maripaludis metabolic processes include acetyl-CoA synthesis, pyruvate synthesis, glycolysis/gluconeogenesis, reductive tricarboxylic acid (RTCA) cycle, non-oxidative pentose phosphate pathway (NOPPP), nitrogen metabolism, amino acid metabolism, and nucleotide biosynthesis .
STRING analysis predicts functional partners of MMP0657 based on neighborhood, gene fusion, co-occurrence, coexpression, experiments, databases, and text mining .
Predicted Functional Partners:
MMP1427: Conserved Hypothetical Protein; Belongs to the UPF0210 family
rpl11: Ribosomal protein L11; Forms part of the ribosomal stalk which helps the ribosome interact with GTP-bound translation factors; Belongs to the universal ribosomal protein uL11 family
MMP1282: Conseved hypothetical protein NTP-binding; Belongs to the UPF0200 family
M. maripaludis is used in a variety of research contexts:
Metabolic Engineering: M. maripaludis can be engineered to produce useful products like terpenoids, hydrogen, and methanol .
Systems Biology: Genome-scale metabolic models (e.g., iMM518) are used to study genetic perturbations and complex biological interactions .
Global Response Studies: Transcriptome arrays and measurements of cellular amino acid pools have been used to determine the response of M. maripaludis to various limitations such as leucine, phosphate, and H2 .
Fe-S Cluster Proteins: M. maripaludis is a model organism for studying iron-sulfur (Fe-S) cluster proteins, which are abundant and essential in methanogenic archaea .
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
The tag type is determined during production. If you require a specific tag, please inform us; we will prioritize its development.
Methanococcus maripaludis is one of the most extensively studied obligate hydrogenotrophic methanogens in archaea research. Its significance stems from its extensive molecular toolbox, which includes transformation capabilities with various shuttle vectors, genome editing through integrative plasmids, markerless mutagenesis procedures, and established CRISPR-mediated genome editing systems . This organism has been successfully metabolically engineered as a cell factory for the production of high-value products such as geraniol and the bioplastic polymer polyhydroxybutyrate . The experimental versatility of M. maripaludis makes it an ideal model for studying archaeal biology and methanogenesis pathways, with significant potential for biotechnological applications in sustainable energy production.
Small proteins of up to ~50 amino acids (including UPF0237 family proteins like MMP0657) present unique research challenges primarily due to their size. These proteins are frequently overlooked in genome annotations and difficult to identify using standard experimental methods . Mass spectrometry (MS) detection is particularly challenging because conventional bottom-up proteomics approaches are biased toward proteins with molecular weights above 10 kDa, which represent roughly >90% of annotated proteomes . Additionally, small proteins have an intrinsic scarcity of necessary cleavage sites, making it difficult to generate MS-detectable peptides with appropriate length (approximately 7 to 40 amino acids) . These limitations span the entire analytical workflow from sample preparation and digestion to data acquisition and analysis, necessitating specialized approaches for small protein research.
Optimal cultivation of M. maripaludis follows a multi-stage scale-up approach with precisely controlled parameters at each stage:
| Culture System | Volume | Agitation | Substrate Addition | Time to Peak OD | Peak OD₅₇₈ | Specific Growth Rate |
|---|---|---|---|---|---|---|
| Serum Bottles | 0.05 L | 500 rpm stirring | H₂/CO₂ at 2 bars once daily | 90 h | 0.65 | - |
| Schott Bottles | 0.4 L | 180 rpm shaking | H₂/CO₂ at 1 bar twice daily | 69 h | 0.6 | - |
| Bioreactor | 1.5 L | Stepwise conservative agitation | Continuous H₂/CO₂ | 92 h | 3.38 | ~0.16 h⁻¹ |
The most successful cultivation strategy involves initial growth in 0.05 L serum bottles, transfer to 0.4 L Schott bottles during exponential phase, and final cultivation in 1.5 L bioreactors . Under optimized conditions with stepwise conservative agitation ramps, cultures can achieve a specific growth rate of ~0.16 h⁻¹ with generation times of ~4.3 h . For large-scale applications, M. maripaludis has been successfully grown in 22 L stainless steel bioreactors with 15 L working volume, representing a 300-fold scale-up from initial serum bottle cultures .
Extracting and purifying small archaeal proteins requires specialized protocols that address their unique characteristics:
Cell lysis optimization: The archaeal cell envelope differs significantly from bacterial cell walls, requiring specialized lysis buffers that effectively disrupt the pseudomurein layer without denaturing small proteins.
Extraction method selection: Traditional precipitation methods often result in loss of small proteins. Recommended approaches include:
Acid extraction (using TCA or formic acid)
Organic solvent extraction (acetonitrile/water mixtures)
Size-selective ultrafiltration with appropriate molecular weight cutoffs
Heat treatment exploitation if the target protein demonstrates thermal stability
Purification strategy: For recombinant proteins, affinity chromatography using fusion tags is effective, but tag size must be considered relative to the small target protein. Size exclusion chromatography with columns optimized for low molecular weight separation provides superior resolution for small proteins compared to ion exchange methods.
Verification approach: Employ multiple orthogonal verification methods:
Top-down mass spectrometry for intact protein analysis
Custom antibody-based detection with appropriate controls
Functional assays specific to the protein's biochemical activity
These methodological considerations are essential for successful isolation of MMP0657 and similar small archaeal proteins while maintaining their native structure and function.
Mass spectrometry characterization of small proteins like MMP0657 requires specialized approaches that differ from standard proteomics workflows :
| MS Approach | Methodology | Advantages for Small Proteins | Technical Considerations |
|---|---|---|---|
| Bottom-up | Protein digestion followed by peptide analysis | - Established workflows - High sensitivity | - Limited peptide generation - Reduced sequence coverage |
| Top-down | Direct analysis of intact proteins | - Complete sequence coverage - Preservation of PTMs - Detection of proteoforms | - Requires specialized instrumentation - Lower sensitivity than bottom-up |
| Data-Independent Acquisition (DIA) | Fragmentation of all ions without precursor selection | - No loss of information - Higher quantitation quality - Reanalysis capabilities | - Complex MS/MS spectra - Requires spectral libraries |
| Parallel Reaction Monitoring (PRM) | Targeted acquisition for specific detection | - Robust quantification - High specificity | - Requires prior knowledge - Limited discovery potential |
| De novo sequencing | Direct peptide sequencing from MS/MS spectra | - Independence from database limitations - Novel sequence identification | - Computationally intensive - Higher error rates |
For optimal characterization of MMP0657, a multi-faceted approach combining top-down analysis for intact protein characterization with targeted bottom-up methods using optimized digestion protocols is recommended . Specialized search parameters must be implemented, including adjustments for semi-tryptic or non-specific digestion, expanded mass tolerance windows, and customized databases that account for small open reading frames often missed in standard genome annotations.
The established CRISPR-Cas systems in M. maripaludis provide powerful tools for functional studies of MMP0657:
Gene knockout studies: CRISPR/Cas12a-based genome editing can efficiently create MMP0657 deletion mutants to evaluate phenotypic effects and establish essentiality . The system functions effectively with homology arms of 500-1000 bp in length, with no significant difference in transformation efficiency between these distances .
Promoter manipulation: CRISPR-based approaches can modify native promoters to create conditional expression systems, enabling temporal control over MMP0657 expression to study its function under different growth conditions.
Protein tagging: The precision of CRISPR editing allows for in-frame fusion of affinity or fluorescent tags to facilitate protein localization and interaction studies without disrupting protein function.
Strain engineering considerations: When implementing CRISPR-based approaches in M. maripaludis, researchers must account for the active PstI restriction modification system, which can digest foreign DNA containing unmethylated PstI sites, reducing transformation efficiency by 1.6-3.4 fold per site . Methylation of transformation constructs or selection of PstI-free designs can significantly improve editing efficiency.
This methodological framework allows researchers to systematically investigate MMP0657 function through precise genetic manipulation while optimizing transformation efficiency.
Distinguishing genuine small proteins from translation artifacts requires a multi-evidence approach:
Integrative omics evidence:
Correlation of ribosome profiling data with transcript evidence (RNA-seq)
Confirmation of translation initiation sites via differential RNA-seq (dRNA-seq) or Ribo-RET techniques
Consistent detection across multiple MS experiments using different sample preparation methodologies
Evolutionary conservation analysis:
Comparative genomics across related archaeal species to identify conserved small ORFs
Evaluation of selection pressure signatures (e.g., Ka/Ks ratios) indicative of functional coding sequences
Structural homology to characterized UPF0237 family proteins
Statistical validation:
Implementation of false discovery rate controls specific to small protein identification
Requirement for multiple unique peptides or high sequence coverage
Benchmarking against negative control datasets (e.g., reverse database searches)
Functional verification:
Phenotypic characterization of knockout or knockdown strains
Interactome analysis to identify binding partners
Biochemical activity assays specific to predicted function
This comprehensive validation framework helps researchers confidently distinguish biologically relevant small proteins like MMP0657 from spurious translation products or annotation artifacts that commonly confound small protein research.
Optimizing recombinant expression of MMP0657 requires consideration of several key factors:
Promoter selection and optimization:
Strong constitutive promoters for maximum expression
Inducible systems for controlled expression
Synthetic promoter engineering based on transcriptomic data from optimal growth conditions
Codon optimization strategies:
Analysis of M. maripaludis codon usage bias
Optimization of rare codons while maintaining mRNA secondary structure
Consideration of translational pausing sites that may affect protein folding
Growth parameter correlation with expression:
Synchronization of induction timing with growth phase
Optimization of H₂/CO₂ feeding strategy to support metabolic burden of recombinant expression
Temperature modulation to balance growth rate with protein folding efficiency
Scale-up considerations:
These approaches should be systematically evaluated using a design of experiments (DOE) framework to identify optimal conditions specific to MMP0657 expression while maintaining the viability and metabolic activity of M. maripaludis.
Structural analysis provides crucial insights into the potential functions of uncharacterized proteins like MMP0657:
Computational structure prediction approaches:
Ab initio modeling using deep learning approaches
Template-based homology modeling using structurally characterized UPF0237 family members
Molecular dynamics simulations to identify flexible regions and potential binding pockets
Experimental structure determination strategies:
X-ray crystallography of recombinant purified protein
NMR spectroscopy particularly suitable for small proteins
Cryo-electron microscopy if the protein forms larger complexes
Structure-function correlation methods:
Structural alignment with functionally characterized proteins to identify conserved motifs
Electrostatic surface potential mapping to predict interaction interfaces
Identification of catalytic residues through structural conservation analysis
Integrative approaches:
Correlation of structural features with transcriptomic responses to environmental conditions
Protein-protein interaction networks informed by structural compatibility
Metabolic context analysis based on genomic neighborhood and operon structure
This multifaceted approach to structural analysis provides a robust foundation for generating testable hypotheses about the biological function of MMP0657 and related UPF0237 family proteins in archaeal metabolism.
Interpretation of mass spectrometry data for small proteins requires specialized analytical considerations:
Database search parameters optimization:
Implementation of custom protein databases that include predicted small ORFs
Adjustment of search parameters to account for limited peptide generation
Consideration of non-specific or semi-specific digestion patterns
Spectral interpretation guidelines:
Manual validation of MS/MS spectra for key peptides
Requirement for multiple fragmentation methods (CID, HCD, ETD) for confident sequence assignment
Assessment of precursor mass accuracy and isotope distribution patterns
Quantification considerations:
Selection of appropriate normalization methods specific to small proteins
Implementation of label-based approaches for improved quantification accuracy
Correlation with orthogonal quantification methods (e.g., targeted PRM assays)
Statistical framework development:
Establishment of appropriate false discovery rate thresholds specific to small proteins
Implementation of Bayesian statistical models that incorporate prior probabilities
Robust outlier detection to identify technical artifacts
These analytical guidelines ensure that mass spectrometry data for MMP0657 and similar small proteins are interpreted with appropriate confidence levels, minimizing both false positives and false negatives that commonly affect small protein research .
Comprehensive bioinformatic analysis can provide valuable insights into potential functions of UPF0237 family proteins:
Sequence-based prediction methods:
Position-specific scoring matrices to identify conserved functional motifs
Machine learning approaches trained on characterized small proteins
Hidden Markov Models (HMMs) based on UPF0237 family alignments
Genomic context analysis:
Operon structure and co-transcription patterns
Phylogenetic profiling to identify co-evolving gene families
Conserved gene neighborhoods across archaeal species
Systems biology integration:
Metabolic network analysis to identify potential biochemical roles
Protein-protein interaction network inference
Gene expression correlation analysis across diverse conditions
Literature mining approaches:
Natural language processing of scientific literature
Automated hypothesis generation from disparate data sources
Knowledge graph construction for archaeal small proteins
These computational approaches provide a framework for hypothesis generation that can guide experimental design for functional characterization of MMP0657, potentially revealing its role in methanogenesis or related archaeal metabolic pathways.
Establishing correlations between growth parameters and protein expression requires systematic data collection and analysis:
| Growth Phase | Typical OD₅₇₈ | Metabolic Characteristics | Expression Optimization Strategy |
|---|---|---|---|
| Lag Phase | <0.2 | Adaptation to environment Low metabolic activity | - Minimize lag phase through optimized inoculum - Pre-adaptation to expression conditions |
| Early Exponential | 0.2-0.6 | Increasing growth rate Active protein synthesis | - Implement induction at this stage for maximum productivity - Balance nutrient availability with oxygen-free conditions |
| Mid Exponential | 0.6-1.5 | Maximum growth rate (μ ≈ 0.16 h⁻¹) Highest metabolic activity | - Optimize H₂/CO₂ delivery to prevent substrate limitation - Implement stepwise conservative agitation ramps |
| Late Exponential | 1.5-3.0 | Decreasing growth rate Potential stress responses | - Determine protein stability and accumulation patterns - Optimize harvesting time for maximum yield |
| Stationary | >3.0 | Growth cessation Metabolic reprogramming | - Evaluate protein degradation profiles - Consider stress-response based expression systems |
This phase-specific approach can be implemented through:
Time-course sampling strategy: Regular sampling throughout the growth curve with parallel protein expression analysis using quantitative proteomics or reporter systems.
Parameter variation studies: Systematic modification of key parameters (temperature, pH, agitation, gas composition) with multivariate analysis of their effects on both growth and protein expression.
Metabolic flux analysis: Correlation of carbon flux through methanogenesis pathways with recombinant protein production to identify potential metabolic bottlenecks.
Scale-up validation: Confirmation that expression patterns observed in small-scale cultures (0.05-0.4 L) translate effectively to larger bioreactors (1.5-15 L) , with adjustments to account for changes in mass transfer and mixing dynamics.
This integrated approach enables researchers to develop optimized production protocols specifically tailored for MMP0657 expression in recombinant M. maripaludis systems.
Future research on MMP0657 should focus on integrating multiple experimental approaches to definitively characterize this small protein:
Comprehensive functional genomics: Systematic phenotypic characterization of knockout strains across diverse environmental conditions, combined with multi-omics profiling to identify affected pathways.
Structural biology initiatives: Determination of high-resolution structures using techniques optimized for small proteins, potentially revealing functional sites and interaction interfaces.
Interactome mapping: Identification of protein-protein and protein-metabolite interactions through approaches like proximity labeling, providing contextual information about cellular roles.
Evolutionary analysis: Comparative studies across diverse archaea to understand the conservation and potential specialized roles of UPF0237 family proteins in different ecological niches.
Biotechnological applications: Exploration of potential applications in methanogen-based biotechnology, including possible roles in enhancing methane production or in metabolic engineering for high-value products.